Page last updated: 2024-08-26

sr141716 and Adenocarcinoma

sr141716 has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castellón, EA; Contreras, HR; Gallegos, I; Huidobro, C; Llanos, MN; Orellana-Serradell, O; Poblete, CE; Sanchez, C	1
Adhami, VM; Afaq, F; Mukhtar, H; Sarfaraz, S	1

Other Studies

2 other study(ies) available for sr141716 and Adenocarcinoma

Article	Year
Proapoptotic effect of endocannabinoids in prostate cancer cells. Oncology reports, 2015, Volume: 33, Issue:4 Topics: Adenocarcinoma; Apoptosis; Arachidonic Acids; Cell Cycle; Drug Screening Assays, Antitumor; Endocannabinoids; Glycerides; Humans; Male; MAP Kinase Signaling System; Neoplasm Proteins; Piperidines; Polyunsaturated Alkamides; Prostatic Hyperplasia; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Signal Transduction; Tumor Cells, Cultured	2015
Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer research, 2005, Mar-01, Volume: 65, Issue:5 Topics: Adenocarcinoma; Apoptosis; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Dose-Response Relationship, Drug; Humans; Male; Morpholines; Naphthalenes; Neoplasms, Hormone-Dependent; Piperidines; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Androgen; Rimonabant; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2005

Article

Year

Proapoptotic effect of endocannabinoids in prostate cancer cells.

Oncology reports, 2015, Volume: 33, Issue:4

Topics: Adenocarcinoma; Apoptosis; Arachidonic Acids; Cell Cycle; Drug Screening Assays, Antitumor; Endocannabinoids; Glycerides; Humans; Male; MAP Kinase Signaling System; Neoplasm Proteins; Piperidines; Polyunsaturated Alkamides; Prostatic Hyperplasia; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Signal Transduction; Tumor Cells, Cultured

2015

Cannabinoid receptor as a novel target for the treatment of prostate cancer.

Cancer research, 2005, Mar-01, Volume: 65, Issue:5

Topics: Adenocarcinoma; Apoptosis; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Dose-Response Relationship, Drug; Humans; Male; Morpholines; Naphthalenes; Neoplasms, Hormone-Dependent; Piperidines; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Androgen; Rimonabant; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005